Intera Oncology Inc. (now a part of Boston Scientific)

Intera Oncology Inc., based in Boston, is a life science and medical device company focused on advancing cancer treatment solutions, particularly for patients with colorectal cancer and intrahepatic cholangiocarcinoma that has spread to the liver. Founded by individuals connected to patients who benefited from Hepatic Artery Infusion (HAI) therapy, the company aims to make this targeted treatment accessible to all eligible patients. The flagship product, the Intera 3000 Hepatic Artery Infusion Pump, is a small, implantable device that delivers chemotherapy directly to liver tumors via the hepatic artery. This method allows for significantly higher drug concentrations at the tumor site compared to traditional systemic chemotherapy, potentially improving patient outcomes and minimizing side effects. Intera Oncology is committed to developing innovative solutions for unmet medical needs in cancer treatment, with a focus on enhancing the quality of life for patients undergoing therapy. The company serves oncology clinics and hospitals that specialize in liver cancer treatment across the U.S.

• Employees 34
• Founded 2019
• Total Funding $3287392